Literature DB >> 19080739

Management of complications from estrogen deprivation in breast cancer patients.

Dawn L Hershman1, Christina Cho, Katherine D Crew.   

Abstract

In the United States today, more than 2 million women live as breast cancer survivors. As the number of cancer survivors grows, the unique long-term side effects of cancer treatment and aging play an increasingly prominent role in the routine care of these patients. Of special concern are the short- and long-term effects of sex hormone deprivation. This article reviews current issues surrounding the acute and late effects associated with hormone deprivation in breast cancer survivors and summarizes the scientific and therapeutic discoveries to date to identify optimal nonestrogenic treatments for symptom control in individual patients.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19080739     DOI： 10.1007/s11912-009-0006-6

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


  62 in total

1.  The effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms of Australian women. A randomised controlled trial.

Authors:  S R Davis; E M Briganti; R Q Chen; F S Dalais; M Bailey; H G Burger
Journal:  Med J Aust       Date:  2001-01-15       Impact factor: 7.738

Review 2.  Sexual functioning in breast cancer survivors.

Authors:  C L Thors; J A Broeckel; P B Jacobsen
Journal:  Cancer Control       Date:  2001 Sep-Oct       Impact factor: 3.302

Review 3.  Effect of postmenopausal hormone therapy on cardiovascular risk.

Authors:  Jacques E Rossouw
Journal:  J Hypertens Suppl       Date:  2002-05

4.  Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial.

Authors:  Ghada El-Hajj Fuleihan; Mariana Salamoun; Yasser Abou Mourad; Aref Chehal; Ziad Salem; Ziyad Mahfoud; Ali Shamseddine
Journal:  J Clin Endocrinol Metab       Date:  2005-03-15       Impact factor: 5.958

5.  Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery?

Authors:  P A Ganz; A C Schag; J J Lee; M L Polinsky; S J Tan
Journal:  Cancer       Date:  1992-04-01       Impact factor: 6.860

6.  Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study.

Authors:  P D Delmas; R Balena; E Confravreux; C Hardouin; P Hardy; A Bremond
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

7.  Weight gain during adjuvant and neoadjuvant chemotherapy for breast cancer: an audit of 100 women receiving FEC or CMF chemotherapy.

Authors:  K J Lankester; J E Phillips; P A Lawton
Journal:  Clin Oncol (R Coll Radiol)       Date:  2002-02       Impact factor: 4.126

8.  Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients.

Authors:  Gary Deng; Andrew Vickers; Simon Yeung; Gabriella M D'Andrea; Han Xiao; Alexandra S Heerdt; Steven Sugarman; Tiffany Troso-Sandoval; Andrew D Seidman; Clifford A Hudis; Barrie Cassileth
Journal:  J Clin Oncol       Date:  2007-12-10       Impact factor: 44.544

9.  Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.

Authors:  T J Powles; T Hickish; J A Kanis; A Tidy; S Ashley
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

10.  Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients.

Authors:  Katherine D Crew; Jillian L Capodice; Heather Greenlee; Arlyn Apollo; Judith S Jacobson; George Raptis; Kimberly Blozie; Alex Sierra; Dawn L Hershman
Journal:  J Cancer Surviv       Date:  2007-10-12       Impact factor: 4.442
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.